Take Action
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Backgrounder
Biosimilars Bulletin
Blog
Council Resource
Event
Handbook
Infographic
Issue Brief
Media
Member Spotlight
Partner Resource
Policy Recommendation
Press Release
Report
Statement
Video
Whitepapers

In the News

Report: Adalimumab Biosimilars Will Increase Competition, but Rebates, Other Barriers Will Impact Savings
February 21, 2023
New IQVIA Report: Biosimilars Driving Lower Prices and Greater Savings
January 31, 2023
Biosimilars Council Launches Educational Research for Leading Biosimilar Research
December 14, 2022
Raising Awareness for Biosimilars for Stakeholders Around the World
November 14, 2022
Biosimilar Medicines Generated $7 Billion in Savings in 2021
September 21, 2022
Senate passes inflation reduction act
AAM Statement on Senate Passage of Inflation Reduction Act
August 7, 2022

Filter by Keyword

Filter by Audience

Filter by Category

Filter by Keyword

Filter by Issue

Filter by Category

Recent Tweets

Biosimilars CouncilFollow2,7889,974

Biosimilars Council advocates for policies that support patient access to biosimilar medicines. Division of @AccessibleMeds | https://t.co/73dlNwCdqQ…

Biosimilars Council
BiosimsCouncil avatarBiosimilars Council@BiosimsCouncil·
29 Mar 1641116351610617857

"We need to create incentives at every piece of the value chain to help biosimilars be successful."

Check out this interview @AccessibleMeds Board Chair Christine Baeder in @BiosimCenter, where she discusses how we can boost #biosimilar adoption.

https://www.centerforbiosimilars.com/view/christine-baeder-discusses-generic-awareness-and-challenges-that-lie-in-biosimilar-in-generic-spaces

Twitter feed video.
Image for the Tweet beginning: "We need to create incentives
Reply on Twitter 1641116351610617857Retweet on Twitter 1641116351610617857Like on Twitter 16411163516106178571Twitter 1641116351610617857
Retweet on TwitterBiosimilars Council Retweeted
AccessibleMeds avatarAAM@AccessibleMeds·
24 Mar 1639311301594976256

Registration is open! Join us on Oct 2-4 for #GRxBiosims 2023, the premier scientific & regulatory & policy event for the U.S. #generics & #biosimilars industry, featuring timely programming relevant to technical, regulatory & policy professionals. https://grxbiosims.org

Twitter feed video.
Image for the Tweet beginning: Registration is open! Join us
Reply on Twitter 1639311301594976256Retweet on Twitter 16393113015949762561Like on Twitter 16393113015949762561Twitter 1639311301594976256
Load More...